Arcus Biosciences (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated ...

For Arcus Orthotics, the name of the game is convenience. Staffed by a team of medical professionals, Arcus is an online custom orthotics company that creates custom insoles for shoppers from the ...

The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $25.8, a high ...

Arcus and AstraZeneca to evaluate their respective molecules in combination to establish a potential first- and best-in-class treatment for clear cell renal cell carcinoma (ccRCC) This is the second ...

Gilead Sciences and Arcus are slimming down a phase 3 TIGIT trial to compare the lung cancer combo therapy to just Merck’s Keytruda, ditching a chemotherapy arm. The move means a little extra cash ...

Fintel reports that on February 12, 2026, Wells Fargo downgraded their outlook for Arcus Biosciences (NYSE:RCUS) from Overweight to Equal-Weight. Analyst Price Forecast Suggests 57.58% Upside As of ...

Presented data from the ongoing ARC-7 Phase 2 trial in non-small cell lung cancer at American Society of Clinical Oncology (ASCO); Fc-silent anti-TIGIT monoclonal antibody domvanalimab continued to ...

Dr. Markus will oversee Arcus’s clinical development organization and portfolio that includes seven clinical-stage programs with multiple ongoing Phase 3 studies HAYWARD, Calif., January 21, ...

Arcus Biosciences presents a high-risk speculation with significant upcoming catalysts, despite recent stock declines and Gilead's exit from the ARC-10 trial. Gilead's continued investment and board ...

An icon in the shape of a lightning bolt. Impact Link While Arcus CEO Edrizio De La Cruz was studying at the University of Pennsylvania's Wharton Business School, he was also trying to come up with ...

Arcus and Gilead announced an additional equity investment of $320 million into Arcus and modifications to their domvanalimab + zimberelimab clinical program to focus on the highest unmet medical ...